Holbrook Kohrt
Publication Details
-
Renal failure and rhabdomyolysis associated with sitagliptin and simvastatin use.
Diabet Med. 2008; (10): 1229-30
Sitagliptin is a new oral glucose-lowering medication that acts via the incretin hormone system. The most common side-effects are headache and pharyngitis, and few serious adverse events were observed during clinical trials. Dose adjustment is recommended in renal insufficiency, but long-term safety experience is limited.
Help
Trial Administration